Algorithms
Researchers from University of Leicester publish findings in algorithms
Published in Diabetes Week, April 14th, 2008
According to a study from Leicester, the United Kingdom, "The AT.LANTUS trial recently demonstrated the efficacy and safety of insulin glargine initiation and maintenance using two different treatment algorithms in poorly controlled type 2 diabetes mellitus (T2DM). This sub-analysis investigated glycemic control and safety in 686 patients switching from premixed insulin (premix) with or without (+/- OADs) to once-daily glargine (+/- OADs/prandial insulin)."
"A 24-week, multinational (n = 59), multicenter (n = 611), randomized study comparing two algorithms (Algorithm 1: clinic-driven titration; Algorithm 2: patient-driven titration) in four glargine OADs treatment...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
Source: Diabetes Week (2008-04-14)
More Articles from Diabetes Week
- Obesity
Increased risk of myocardial infarction and diabetes in East Germany - Prostate Cancer
Potential association of type 2 diabetes genes with prostate cancer - Type 2 Diabetes
Major collaboration uncovers surprising new genetic clues to diabetes - Type 2 Diabetes
Study indicates diabetes medication may help slow plaque build-up in coronary arteries - Arthritis
Research from University of Otago has provided new information about arthritis - Depression
Study findings on depression are outlined in reports from S.L. Swenson and colleagues - More from this issue of Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
